Exosens Stock Sets a New Historical Record After a 155% Increase Over One Year
Exosens reached a new historical peak this Friday, February 27, 2026, briefly surpassing 62.50 euros during the session. However, the stock closed slightly lower by 0.16% at 62.30 euros, very close to this high. Over one year, the performance remains exceptional with a 155% increase.
Record-Breaking Performance in Trading Session
During the session, the Exosens stock exceeded its previous record of 62.50 euros, set the day before, before settling back to close at 62.30 euros. This new high comes after a nearly 52% increase over three months, driven by a sustained upward momentum.
The analysis of moving averages reflects the strength of this trend: the price is now significantly above its 50-day moving average, located at 53.79 euros, a gap of more than 15%. This significant discrepancy indicates a marked recent acceleration. The RSI, at 72, also signals that the stock is in an overbought zone, a level that historically can precede phases of consolidation or technical correction. The nearest resistance corresponds to today's peak at 62.50 euros, while the stock tests the limits of its upper Bollinger band, positioned at 62.79 euros.
Analyst Recommendations and Updates
Regarding analyst recommendations, two institutions have recently updated their views on the stock. JP Morgan raised its price target from 60 to 71 euros on February 26, while maintaining an 'overweight' rating. This new target represents a potential upside of about 14% from the current price of 62.30 euros, reflecting the American bank's confidence in the prospects of the group specializing in photon detection and amplification technologies.
Deutsche Bank was more cautious. The German institution raised its target from 52 to 55 euros on February 25, with a 'hold' recommendation. This target is nearly 12% below the closing price, reflecting a more prudent view of the current valuation. The next key date on the financial calendar: the release of the first quarter results, expected on April 27, 2026, could provide new insights into Exosens' operational trajectory.
